RLAY — Relay Therapeutics Inc

Ownership history in Alphabet Inc.  ·  14 quarters on record

This page tracks every 13F SEC filing in which Alphabet Inc. reported a position in Relay Therapeutics Inc (RLAY). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
1.79% (2022 Q3)
Avg. % of fund
0.76%
First filed
2022 Q3
Last filed
2025 Q4
Quarters held
14
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 UNCHANGED 1,568,753 — 0% 0.51% $13.3M $8.46
2025 Q3 UNCHANGED 1,568,753 — 0% 0.34% $8.2M $5.22
2025 Q2 UNCHANGED 1,568,753 — 0% 0.25% $5.4M $3.46
2025 Q1 UNCHANGED 1,568,753 — 0% 0.26% $4.1M $2.62
10 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    RLAY price (monthly, adj. close)

Other funds also holding RLAY

As of 2025 Q4 — sorted by position size

Commodore Capital LP 3Y 9.57% Casdin Capital, LLC 3Y 7Y 6.83% Foresite Capital Management IV, LLC 3Y 7Y 3.68% SB INVESTMENT ADVISERS (UK) LTD 3Y 7Y 2.36% MPM BioImpact LLC 3Y 2.16% Elmind Capital, LP 1.34% Bellevue Group AG 3Y 7Y 1.34% HighVista Strategies LLC 3Y 7Y 1.19% TCG Crossover Management, LLC 3Y 0.9% Kynam Capital Management, LP 3Y 0.77%
← Back to Alphabet Inc. Holdings